The Patent Finder

Terms ending in 2030

Hoffmann-La Roche Inc.

Every in-force patent on Hoffmann-La Roche Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,600,781Tumor-Targeted Agonistic CD28 Antigen Binding Molecules
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 8,268,314Bispecific ANTI-VEGF/ANTI-ANG-2 Antibodies
In force
 · High confidence
Hoffmann-La Roche, Inc.In forceHigh confidence
US 9,073,986Antibodies Against Human Angiopoietin 2
In force
 · Medium confidence
Hoffmann-La Roche Inc.In forceMedium confidence
US 9,080,183Promoter
In force
 · High confidence
Hoffmann-La Roche, Inc.In forceHigh confidence
US 8,614,297Anti-Idiotype Antibody Against an Antibody Against the Amyloid Beta Peptide
In force
 · High confidence
Hoffmann-La Roche, Inc.In forceHigh confidence
US 9,663,517Compositions and Uses Thereof
In force
 · High confidence
Hoffman-la Roche Inc.In forceHigh confidence
US 9,890,204Trivalent, Bispecific Antibodies
In force
 · Medium confidence
Hoffmann-La Roche Inc.In forceMedium confidence
US 10,640,555Bispecific Antigen Binding Proteins
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 8,354,444Substituted PYRROLIDINE-2-Carboxamides
In force
 · Medium confidence
F. Hoffmann-La Roche AGIn forceMedium confidence
US 10,711,298Oligonucleotide Detection Method
In force
 · High confidence
Axolabs GmbHIn forceHigh confidence
32 more term ends in 2030 · Pro
10 of 42 patents shown. Soonest term end first, then patent number.
Pro members see all 42.
Upgrade to Pro
38 of these are in force and held by Hoffmann-La Roche Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited